NOVARTIS PHARMACEUTICALS CORPORATION - LUTATHERA CANCER THERAPY

PIID: 36C26126F0008

Signed Date: Oct 1, 2025Effective Date: Oct 1, 2025End Date: Closes in 110 days

Award $

$680K

Vendor

NOVARTIS PHARMACEUTICALS CORPORATION

NAICS

325412

Signed Date

Oct 1, 2025

Key Details

Dollars Obligated

$679,948.64

Base & All Options

$3.4M

Awarding Agency

Awarding Sub-Agency

Department of Veterans Affairs

NAICS Code

Product Service Code

6505 - DRUGS AND BIOLOGICALS

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

EAST HANOVER, NJ, 079361080, CD-NJ-11

LUTATHERA CANCER THERAPY

On Oct 1, 2025, Department of Veterans Affairs obligated $679,948.64 to NOVARTIS PHARMACEUTICALS CORPORATION for lutathera cancer therapy. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in EAST HANOVER, NJ. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining.